Our Favorite Resources for
-
A nonprofit website dedicated to providing the most reliable and complete information available.
Breastcancer.org -
Provides educational materials, events, newsletters, a Young Survivors Network, and a toll-free helpline at 800-753-5222.
Living Beyond Breast Cancer -
A comprehensive site that offers a toll-free helpline (1-800-I'M AWARE), educational materials, advocacy, and fundraising events.
Susan G. Komen for the Cure
INFORMATION BY CANCER TYPE
Breast - More Stories
|
|
Nov 11, 2008Colorectal Cancer, Lung Cancer & Lymphoma New approvals for colorectal, lung, breast, head & neck cancer and lymphoma. |
|
|
Nov 11, 2008Breaking News from ASH and SABCS Updates from the American Society of Hematology Meeting and the San Antonio Breast Cancer Symposium. |
|
|
Oct 28, 2008Dr. Aman Buzdar discusses the latest breast cancer treatment strategies with aromatase inhibitors. |
|
|
Oct 23, 2008An approval in breast cancer, positive clinical trial results in liver cancer, while a prostate cancer drug disappoints. |
|
|
Oct 23, 2008Breast Cancer, Liver Cancer & Leukemia Recent drug approvals yield a new chemotherapy agent, a first for liver cancer, a safer prevention method, and good news for a drug-resistant cancer. |
|
|
Oct 23, 2008Researchers Focus On Hormone-Negative Breast Cancer Women with hormone-negative breast cancers may not be able to benefit from tamoxifen and aromatase inhibitors, but a subset of patients with HER2-positive breast cancer are able to take advantage of advances such as Herceptin and Tykerb. For women with hormone- and HER2-negative cancers, or triple negative, new research into what drives these cancers and prevent recurrence may increase treatment options and benefit this population. |
|
|
Oct 23, 2008The challenges of breast cancer in women under 40. |
|
|
Oct 22, 2008Cancer survivors deal with fear. |
|
|
Oct 22, 2008This article discusses premature menopause as a result of cancer treatments. |
|
|
Oct 22, 2008The individual & family decisions behind testing for genetic cancer risk. |
TEXT SIZE 